ArticleBMC public health2025
Unequal disease burdens: exploring the intersection of gender, health and disease dynamics in China.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Trends in Emergency Department utilization by disease categories in a migrant-dense high-income setting: a retrospective study in Dubai, 2021-2025.International journal of emergency medicine · 2026Article
- The Impact of Population Aging on Ergonomic-Related Low Back Pain Across Regions with Different Development Levels.Journal of pain research · 2026Article
- Integrating migration into cancer geography: spatial clustering of five digestive cancer burden in China.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGender differences have a significant impact on disease burden. Although there is extensive research on disease burden in China, the age-related and long-term trends in gender differences for major diseases are not clear. This study analyzes the gender differences in the burden of 20 major diseases in China from 1990 to 2021, revealing temporal and age-related trends, and providing evidence for gender-sensitive public health policies.
methodsThis study uses data from the Global Burden of Disease Study 2021 (GBD 2021) to analyze gender differences in 20 major diseases in China. Absolute differences (male DALY − female DALY) and relative differences (absolute difference / male DALY × 100%) were calculated to analyze the long-term trends and age-related characteristics of gender differences across different age groups (0–14 years, 15–49 years, 50–69 years, 70 + years).
resultsIn 2021, diseases with a significantly higher burden for males included stroke (male 31,862,593.3 vs. female 21,328,097.8; absolute difference 10,534,495.5, relative difference 33.1%), cirrhosis and other chronic liver diseases (relative difference 69.3%), and lung cancer (absolute difference 6,743,543.2). Alzheimer’s disease and other dementias were the only diseases with a higher burden in females (female 6,500,198.7 vs. male 3,572,278.8; relative difference − 82%). Gender differences were present in early childhood, especially in neonatal disorders and road injuries, while stroke showed the largest gender difference in the elderly. Between 1990 and 2021, the gender difference in diabetes mellitus declined (from 8.1% lower in males to 10.3% higher in males). The gender gap continued to widen for cirrhosis (relative difference increased from 55.1 to 69.3%) and ischemic heart disease (from 19.7 to 34.3%).
conclusionOver the past 30 years, gender differences in disease burden in China have changed dynamically, influenced by biological, behavioral, and sociocultural factors. Public health policies should focus on high-risk behaviors in males, such as smoking, drinking, and occupational exposure, by implementing cardiovascular disease and cancer screening programs. For elderly females, a community care network for dementia and early intervention for postmenopausal metabolic diseases should be established. Optimizing healthcare resource allocation and promoting targeted interventions can reduce gender health inequalities. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.